Medistim

Earnings Release • Mar 24, 2015

Financial statements for Medistim ASA for 2014

Financial statements for Medistim ASA for 2014

The Board of Medistim ASA has approved the Annual

Accounts for 2014. The Annual Accounts were

determined without changes from the preliminary

Annual Accounts published on the 26th of February

2015. The Annual General Meeting will be held on 23

of April 2015, and the share will be listed ex

dividend NOK 1.40 per share on the 24th of April

The Annual Report for 2014 will be published on the

company's website and notified to the Oslo Stock

Exchange in April 2015.

About Medistim

Medistim is a Norwegian medtech company listed on

Oslo Stock Exchange (OSE:MEDI). The company is the

world leader within development, manufacturing and

sales of medical equipment for use in quality

assessment of cardiac-, vascular and transplant

surgery procedures. Cardiovascular diseases are a

common cause of death in the western world, and

about 700.000 cardiac bypass surgery procedures and

600.000 vascular surgery procedures are performed

globally every year. Medistim was established in

1984, and has a track record of profitable growth.

The company is a pioneer within its segment, and

continues to invest in new product development.

Medistim has wholly owned subsidiaries with sales

organizations in the USA, Germany, UK, Denmark and

Norway, in addition to the about 50 distributors in

Europe, Asia, Middle East, Africa and South

America. For more information, visit the Medistim

home page: www.medistim.com